BE528021A - - Google Patents
Info
- Publication number
- BE528021A BE528021A BE528021DA BE528021A BE 528021 A BE528021 A BE 528021A BE 528021D A BE528021D A BE 528021DA BE 528021 A BE528021 A BE 528021A
- Authority
- BE
- Belgium
- Prior art keywords
- base
- tartrate
- tetrahydro
- naphthyl
- optically active
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 25
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 6
- FEWJPZIEWOKRBE-LWMBPPNESA-N levotartaric acid Chemical compound OC(=O)[C@@H](O)[C@H](O)C(O)=O FEWJPZIEWOKRBE-LWMBPPNESA-N 0.000 claims description 6
- 150000003839 salts Chemical class 0.000 claims description 5
- 229960001270 d- tartaric acid Drugs 0.000 claims description 4
- BEBCJVAWIBVWNZ-UHFFFAOYSA-N glycinamide Chemical compound NCC(N)=O BEBCJVAWIBVWNZ-UHFFFAOYSA-N 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 230000003287 optical effect Effects 0.000 claims description 3
- 238000001640 fractional crystallisation Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 229940095064 tartrate Drugs 0.000 description 12
- 235000019441 ethanol Nutrition 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229960001367 tartaric acid Drugs 0.000 description 3
- 239000011975 tartaric acid Substances 0.000 description 3
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 239000000155 melt Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 239000000219 Sympatholytic Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 230000002196 ecbolic effect Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000000948 sympatholitic effect Effects 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE528021A true BE528021A (cs) |
Family
ID=161460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE528021D BE528021A (cs) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE528021A (cs) |
-
0
- BE BE528021D patent/BE528021A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2550788A1 (fr) | Nouveau procede de preparation d'a-6-desoxytetracyclines | |
| EP0479631A1 (fr) | Dérivés du spiro [4.5]décane leur procédé de préparation et les compositions pharmaceutiques les renfermant | |
| RU2163595C2 (ru) | Способ получения энантиомерно чистой азетидин-2-карбоновой кислоты | |
| BE528021A (cs) | ||
| JP2025072534A (ja) | メチルｔｅｒｔ－ブチルエーテル（ＭＴＢＥ）および５重量％未満の脂肪族逆溶媒中での５－メトキシ－Ｎ，Ｎ－ジメチルトリプタミン（５－ＭｅＯ－ＤＭＴ）の再結晶 | |
| EP0279716B1 (fr) | Procédé de n-omega-trifluoroacetylation des alpha,omega diaminoacides monocarboxyliques aliphatiques saturés | |
| EP0074903A2 (fr) | Dérivés d'amino-2 tétrahydro-1,2,3,4 naphtalène, leur préparation et leur application en thérapeutique | |
| US4542235A (en) | Method for producing an optically active 2,2-dimethylcyclopropanecarboxylic acid | |
| EP0023178B1 (fr) | Procédé de préparation de solutions concentrées d'amygdaline sous sa forme naturelle | |
| US2921959A (en) | Process of resolving dl-serine | |
| JPH0558970A (ja) | 含窒素ペルフルオロカルボン酸の光学活性体及びその製造方法 | |
| CH395110A (de) | Procédé de préparation de la dibenzyloxyphosphorylcréatinine | |
| BE901069A (fr) | Procede de synthese d'acide ursodesoxycholique conjugue avec la taurine et produit ainsi obtenu. | |
| EP0946467A1 (fr) | Procede de dedoublement de composes 1-amino-alcan-2-ol | |
| JPH01221345A (ja) | マンデル酸誘導体の光学分割方法 | |
| EP1589019B1 (de) | Stereoselektives Verfahren zur Herstellung von Clopidogrel | |
| EP0453330B2 (fr) | Procédé de préparation du (-) (2R, 3S)-2,3-époxy-3-(4-méthoxyphényl)propionate de méthyle et de son énantiomère | |
| BE837320A (fr) | Derives ethers de 3-amino-1,2-propanodiol | |
| FR2547726A1 (fr) | Acide 2-(4-biphenylyl)-4-hexenoique et ses derives ayant une activite anti-inflammatoire | |
| BE421177A (cs) | ||
| CH637967A5 (fr) | Produit d'addition du n,n-dimethylacetamide et d'un derive d'un acide cephem-4-carboxylique et procede de sa preparation. | |
| CH330821A (fr) | Procédé de dédoublement de la DL-sérine | |
| CH398600A (fr) | Procédé de préparation de composés chimiques thérapeutiquement actifs | |
| JPH023627A (ja) | 光学活性１−メチル−３−フェニルプロピルアミンの製造法 | |
| FR2487828A1 (fr) | Procede de preparation de prostaglandine f2a stable, cristalline, fondant au-dessus de 35 oc a partir de prostaglandine f2a impure contenant de 50 a 98 % de prostaglandine f2a |